Use of Clinical Outcome Assessments in New Drug Approvals by the US Food and Drug Administration Divisions of Neurology I and II
Author(s) -
Yvette Schein,
Holly Fernandez Lynch
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.30530
Subject(s) - food and drug administration , drug , neurology , drug approval , medicine , administration (probate law) , drug administration , clinical pharmacology , new drug application , drug development , intensive care medicine , pharmacology , psychiatry , political science , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom